AAPL vs ABUS · P/E 39, rev $416.16B vs P/E 5.4, rev $6.2M
Apple Inc (AAPL) versus Arbutus Biopharma Corp (ABUS) — a side-by-side from cached financials, not a winner call.
Apple Inc (AAPL) is a consumer electronics company listed on US. It is led by Tim Cook.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Latest reported AAPL revenue for 2025-09-27 was $416.16B. Net income was $112.01B. AAPL currently screens at market cap $3.83T and trailing P/E 39.2.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
AAPL currently screens at market cap $3.83T and trailing P/E 39.2. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Not investment advice. Open the AAPL and ABUS stock pages for the full models.
Not investment advice.